# HOYA CORPORATION

> HOYA CORPORATION is a VC fund in Tokyo backing Medical Device and Health Care. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 6
- Last investment: Sep 2021
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/hoya/about/
- Website: http://www.hoya.co.jp

HOYA CORPORATION is a VC fund in Tokyo focused on Medical Device and Health Care. HOYA CORPORATION is engaged in the manufacture and sale of electronics-related products, imaging products, healthcare products and medical products. The Company operates in three business segments The Information and Communication business segment has two divisions. The Electronics division offers photomasks and mask blanks for semiconductors,liquid crystal displays masks and hard drive (HDD) for glass disk use. The Image division provides optical lens, digital camera modules and optical devices, among others. The Life Care segment has two divisions. The Healthcare division offers ophthalmic lenses and contact lenses. The Medical division provides endoscopes, intraocular lenses and artificial bones. The Others segment is involved in the building of information systems. On October 1, 2011, the Company established a wholly owned subsidiary to takeover the manufacture and sale of imaging system from HOYA, and sold all shares of the newly established subsidiary to Ricoh Company, Ltd.

## Contacts

5 contacts available for HOYA CORPORATION. Shizune tracks 3 team members at HOYA CORPORATION. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/hoya-corporation?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 4 | 67% |
| Health Care | 3 | 50% |
| Medical | 2 | 33% |
| Biotechnology | 2 | 33% |
| Manufacturing | 2 | 33% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 33% |
| Series C | 2 | 33% |
| Series A | 1 | 17% |
| Corporate Round | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 4 | 67% |
| Israel | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hiroshi Hamada | COO | 0 | https://shizune.co/investors/profile/hiroshi-hamada |
| Hiroshi Suzuki | President and CEO | 0 | https://shizune.co/investors/profile/hiroshi-suzuki |
| Kenji Ema | CFO | 0 | https://shizune.co/investors/profile/kenji-ema |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cryosa | CryOSA is a medical device company developing novel treatments for obstructive sleep apnea. | $21.5M | Series B | Sep 23, 2021 |  |
| Cryosa | CryOSA is a medical device company developing novel treatments for obstructive sleep apnea. | $8.3M | Series A | Jun 25, 2020 |  |
| Anchora Medical | Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery. | $4.5M | Series B | Feb 26, 2020 |  |
| Novuson Surgical | Novuson, a spinout from the University of Washington’s highly regarded Applied Physics Laboratory’s Center for Industrial and Medical Ultrasound, is developing its Direct Therapeutic Ultrasound (DTU) technology platform for coagulation and hemostatic control in surgical and trauma procedures. DTU technology should enable clinicians to performsurgeries more quickly and to rapidly control bleeding associated with traumatic injuries. The company founders are Stuart B. Mitchell, PhD. and Francesco P. Curra, Ph.D.Novuson creates tools that reduce operational cost and operating time, eliminating bleeding complications and enhancing patient outcomes. These automatic devices use direct therapeutic ultrasound energy for fast and robust hemostasis, cauterization and division. The devices cauterize tissue from the inside out, creating a well-defined, controlled plane of cauterization. The company was founded in 2014 and based in Bothell, Washington. |  | Corporate Round | May 28, 2019 |  |
| InnFocus | InnFocus is a biomaterials company, develops and provides products in ophthalmology. The company's product portfolio includes an intraocular lens for microincision surgery and an implantable device for glaucoma. The company was incorporated in 2003 and is based in Miami, Florida. | $33.9M | Series C | Dec 23, 2015 |  |
| Xponent | Xponent Photonics, Inc. manufactures surface mount photonic components for optical assemblies. It offers triplexers and diplexers for single-fiber applications, including PON, point-to-point, and bidirectional radio frequency (RF) systems. Xponent Photonics serves optical systems vendors, transceiver suppliers, and optical subsystem suppliers. Thecompany was formerly known as cQuint Communications Corporation and changed its name to Xponent Photonics, Inc. in March 2002. | $23M | Series C | Mar 29, 2007 |  |

6 of 6 investments shown.

## Co-investors
- [Sante Ventures](https://shizune.co/investors/profile/sante-ventures) — VC Fund, 2 deals together
- [Alon Medtech Ventures](https://shizune.co/investors/profile/alon-medtech-ventures) — VC Fund, 1 deal together
- [American River Ventures](https://shizune.co/investors/profile/american-river-ventures) — VC Fund, 1 deal together
- [Arcturus Capital](https://shizune.co/investors/profile/arcturus-capital) — VC Fund, 1 deal together
- [Brightstone Venture Capital](https://shizune.co/investors/profile/brightstone-venture-capital) — VC Fund, 1 deal together
- [Crown Venture Fund](https://shizune.co/investors/profile/crown-venture-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does HOYA CORPORATION invest in?

HOYA CORPORATION invests primarily in Medical Device, Health Care and Medical startups, most often at Series B and Series C stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact HOYA CORPORATION?

Public channels for HOYA CORPORATION include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at HOYA CORPORATION?

The team at HOYA CORPORATION includes Hiroshi Hamada (COO), Hiroshi Suzuki (President and CEO) and Kenji Ema (CFO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co